Death from S. pneumoniae in HbSC Disease: Was Expanded Pneumococcal Vaccination Too Late?

Area of Science:

• Pediatrics
• Infectious Diseases
• Hematology

Background:

• Invasive pneumococcal disease (IPD) poses a significant risk to individuals with sickle cell disease (SCD) due to functional asplenia.
• Vaccination against Streptococcus pneumoniae is proven effective but underutilized in the U.S. (only 70% coverage).
• IPD complications in SCD patients can include sepsis and fat embolism syndrome.

Purpose of the Study:

• To highlight the risk of IPD in vaccinated adolescent SCD patients.
• To emphasize the critical need for early and complete pneumococcal vaccination in SCD.
• To underscore the potential benefit of expanded pneumococcal vaccines for this population.

Main Methods:

• Case report of an adolescent male with Hemoglobin SC (HbSC) disease.
• Presentation to a pediatric emergency department with acute symptoms.
• Clinical course monitoring including rapid deterioration.

Main Results:

• The patient, despite adherence to some vaccination guidelines, succumbed to IPD less than 12 hours after symptom onset.
• Rapid progression to acute respiratory failure, coagulopathy, and multiorgan dysfunction syndrome.
• The case involved a patient with a milder SCD genotype (HbSC).

Conclusions:

• Invasive pneumococcal disease remains a critical threat to vaccinated adolescent SCD patients, irrespective of SCD severity.
• Complete and timely pneumococcal vaccination, including newer formulations, is paramount for preventing severe outcomes in SCD.
• Pediatric and adolescent healthcare providers must remain vigilant regarding IPD risk in all SCD patients.